MedWatch

Venture funds see golden opportunities in Oresund's life science hub

Hundreds of life science companies with over 42,500 employees have made the Oresund region an eldorado for venture funds looking for investment opportunities. "More attracts more," says one of the companies that have become keen on the region's life science hub.

They are innovative, progressive and full of ideas. The number of life science companies in the Oresund region has increased to the extent that the area around Copenhagen and the Southern Sweden have developed into an actual life science hub.

The high concentration of companies in a relatively limited geographical area also makes the region attractive for venture funds looking for golden opportunities in their pursuit of new billion-dollar companies like Novo Nordisk and Genmab.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

CHMP godkender seks lægemidler

Det europæiske lægemiddelagenturs ekspertkomite har på dets møde i oktober indstillet til, at seks nye lægemidler sendes på markedet i Europa – heriblandt et middel baseret på Genmabs teknologi. Samtidig anbefaler komiteen, at ti lægemidler kan bruges på nye måder.

Relaterede

Trial banner

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier